Aclaris Therapeutics to Participate in Two March Healthcare Conferences

Rhea-AI Summary

Aclaris Therapeutics (NASDAQ: ACRS), a clinical-stage biopharmaceutical company specializing in immuno-inflammatory diseases, has announced its participation in two major healthcare conferences this March.

The company's leadership team, led by CEO Dr. Neal Walker, will engage in:

• A fireside chat at the Leerink Partners Global Healthcare Conference in Miami, Florida on March 11, 2025, at 3:00 PM EDT
• A virtual fireside chat during the H.C. Wainwright 3rd Annual Autoimmune & Inflammatory Disease Virtual Conference on March 27, 2025, at 9:00 AM EDT

Both events will be webcast live and archived on the Events page of Aclaris' website, remaining accessible for at least 30 days following the presentations.

News Market Reaction – ACRS

-1.53%

1 alert

-1.53% News Effect

On the day this news was published, ACRS declined 1.53%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

WAYNE, Pa., March 04, 2025 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today announced that the Company will participate in two upcoming healthcare conferences in March.

• On Tuesday March 11, 2025, at 3:00 PM EDT, Aclaris’ Chief Executive Officer Dr. Neal Walker and other members of Aclaris’ senior leadership team will participate in a fireside chat during the Leerink Partners Global Healthcare Conference in Miami, Florida.
  
  
• On Thursday March 27, 2025, at 9:00 AM EDT, Dr. Walker and other members of Aclaris’ senior leadership team will participate in a virtual fireside chat during the H.C. Wainwright 3rd Annual Autoimmune & Inflammatory Disease Virtual Conference
  

A live and archived webcast of both events will be accessible on the Events page of https://www.aclaristx.com/. The webcasts will be available on the Aclaris website for at least 30 days.

About Aclaris Therapeutics, Inc.

Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a pipeline of novel product candidates to address the needs of patients with immuno-inflammatory diseases who lack satisfactory treatment options. The company has a multi-stage portfolio of product candidates powered by a robust R&D engine. For additional information, please visit www.aclaristx.com and follow Aclaris on X (formerly Twitter) at @AclarisTx and on LinkedIn.

Aclaris Therapeutics Contact:

Will Roberts
Senior Vice President
Corporate Communications and Investor Relations
(484) 329-2125
wroberts@aclaristx.com

FAQ

When is Aclaris Therapeutics (ACRS) presenting at the Leerink Partners Conference in March 2025?

Aclaris will present on Tuesday, March 11, 2025, at 3:00 PM EDT at the Leerink Partners Global Healthcare Conference in Miami, Florida.

How can investors watch Aclaris Therapeutics' (ACRS) March 2025 conference presentations?

Investors can access live and archived webcasts of both presentations through the Events page on Aclaris' website (aclaristx.com) for at least 30 days after the events.

What healthcare conferences is Aclaris Therapeutics (ACRS) attending in March 2025?

Aclaris is participating in the Leerink Partners Global Healthcare Conference and the H.C. Wainwright 3rd Annual Autoimmune & Inflammatory Disease Virtual Conference.

When is Aclaris (ACRS) participating in the H.C. Wainwright Virtual Conference?

Aclaris will participate in a virtual fireside chat on Thursday, March 27, 2025, at 9:00 AM EDT during the H.C. Wainwright conference.